Back to top
more

Centene (CNC)

(Delayed Data from NYSE)

$57.46 USD

57.46
8,033,594

-1.22 (-2.08%)

Updated Nov 15, 2024 04:00 PM ET

After-Market: $57.43 -0.03 (-0.05%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.10%
2Buy17.80%
3Hold9.50%
4Sell2.70%
5Strong Sell2.70%
S&P50011.20%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value F Growth C Momentum C VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 33% (82 out of 250)

Industry: Medical - HMOs

Zacks News

Swarup Gupta headshot

Could April be a Better Month for Stocks? 5 Large-Cap Picks

Historical data shows that the Dow has gained 1.9% on average during April since 1950.

    Seagate Technology, Cadence Design Systems, NVIDIA, Micron and Centene highlighted as Zacks Bull and Bear of the Day

    Seagate Technology, Cadence Design Systems, NVIDIA, Micron and Centene highlighted as Zacks Bull and Bear of the Day

      Mark Vickery headshot

      Time to Learn from the Facts: Global Week Ahead

      Bond market economists and stock strategists alike consider the huge flow of macro data out in the first week of a month ??? particularly payrolls in the USA, inflation in Europe, and manufacturing PMIs everywhere ??? to be catalysts for changes to their quarterly and annual outlooks, on rates and on stock prices, respectively.

        Zacks.com highlights: Pioneer Natural Resources, Centene, Mammoth Energy Services, Stoneridge and FTI Consulting

        Zacks.com highlights: Pioneer Natural Resources, Centene, Mammoth Energy Services, Stoneridge and FTI Consulting

          The Zacks Analyst Blog Highlights: Facebook, Centene, Nitto Denko and TIM Participacoes SA

          The Zacks Analyst Blog Highlights: Facebook, Centene, Nitto Denko and TIM Participacoes SA

            Here's Why You Should Steer Clear of DENTSPLY (XRAY) for Now

            DENTSPLY SIRONA (XRAY) faces foreign exchange woes and chances of margin decline in the quarters ahead.

              Nilanjan Choudhury headshot

              Enhance Your Returns With 5 Relative Price Strength Stocks

              Want to try an out-of-the-box approach to earn handsome returns? Tap these stocks with explosive relative price strength.

                John Blank headshot

                More Angst About Facebook: Global Week Ahead

                It looks like a quiet Global Week Ahead. This happens towards the end of any month. These are, for the most part, a continuation of worries that surfaced in recent weeks. Nothing is 'new' news.

                  Zacks.com featured highlights include: Dine Brands, Builders FirstSource, Centene, Encore Wire and HFF

                  Zacks.com featured highlights include: Dine Brands, Builders FirstSource, Centene, Encore Wire and HFF

                    5 Best Momentum Stocks to Buy Using Driehaus Strategy

                    Investors with a high risk appetite might give the Driehaus strategy a thought to boost returns.

                      Tirthankar Chakraborty headshot

                      New Strong Buy Stocks for March 21st

                      Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List for Wednesday

                        5 Reasons Why Centene is an Attractive Bet for Investors

                        Centene (CNC) can be considered a lucrative investment option on the back of top-line growth, inorganic strategies and a solid financial health.

                          Should Value Investors Pick Centene Corporation (CNC) Stock?

                          Let's put Centene Corporation (CNC) stock into this equation and find out if it is a good choice for value-oriented investors right now.

                            Centene Makes Investment in RxAdvance, Builds Partnership

                            Centene's (CNC) transformative alliance with RxAdvance is another instance of Health insurers joining forces with pharmacy benefit managers to reduce the costs in the drug supply chain.

                              Cigna on Raters' Radar After Express Scripts Bid, Stock Down

                              Cigna (CI) gets rating downgrade on a number of concerns related to the Express Scripts deal.

                                Tirthankar Chakraborty headshot

                                5 Top Stocks to Make the Most of March Madness

                                March Madness tournaments mostly concur with strong stock gains. The phenomenon starts from the second week of March and lasts through the first week of April.

                                  Shrug Off Market Gyrations With These Top 5 Value Picks

                                  Despite a recovery from recent correction, several concerns plague the investors. A global trade war, hike in interest rate and an inflationary tendency in the U.S. economy are major near-term concerns.

                                    Why Is Centene (CNC) Down 2.6% Since its Last Earnings Report?

                                    Centene (CNC) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

                                      The Zacks Analyst Blog Highlights: Centene, Macy's, LyondellBasell, Huntington Ingalls and Lam Research

                                      The Zacks Analyst Blog Highlights: Centene, Macy's, LyondellBasell, Huntington Ingalls and Lam Research

                                        3 Reasons Why You Should Invest in athenahealth (ATHN) Stock

                                        athenahealth (ATHN) rides on solid fourth-quarter results and strong fundamentals.

                                          Swarup Gupta headshot

                                          Are Tariff War Fears Overblown? 5 Great Value Choices

                                          Trump's NAFTA related comments show that the President is yet to make up his mind on tariff-related announcements.

                                            ResMed (RMD) Rides High on Robust Global Growth & Innovation

                                            ResMed (RMD) consistently invests and expands globally in high-growth markets like China, South Korea, India, Brazil and across the Eastern Europe belt.

                                              Varian (VAR) Rides on Diverse Product Line, Competition Rife

                                              Varian Medical (VAR) has a strong international presence and growing proton therapy market. However, intense competition adds to woes.

                                                Stryker Closes Entellus Buyout, Bolsters Neurotechnology Line

                                                Stryker (SYK) maintains its acquisition-driven strategy to provide superior and more economic patient experiences.

                                                  Cardiovascular Systems Gains From 510K for OrbusNeich Device

                                                  Cardiovascular Systems (CSII) to distribute limited editions of both 1.0-4.0mm Sapphire II PRO and 2.0-4.0mm Sapphire NC Plus non-compliant coronary balloons post the product launches in the market.